About Leiutis
Leiutis is a company based in Hyderabad (India) founded in 2012. It operates as a B2B. The company has 66 employees as of October 31, 2024. Leiutis offers products and services including Nanotherapeutics for Pain Management, Nanotherapeutics for Supportive Care, Nanotherapeutics for CNS Disorders, and Nanotherapeutics for Immunomodulators. Leiutis operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Hyderabad, India
- Employees 66 as on 31 Oct, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Leiutis Pharmaceuticals Llp
- Date of Incorporation 17 May, 2021
- Jurisdiction Rangareddy, Telangana, India
-
Annual Revenue
$10.25 M (USD)0as on Mar 31, 2024
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
66
as on Oct 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Leiutis
Leiutis offers a comprehensive portfolio of products and services, including Nanotherapeutics for Pain Management, Nanotherapeutics for Supportive Care, Nanotherapeutics for CNS Disorders, and Nanotherapeutics for Immunomodulators.
Innovative nanotechnology-based solutions for effective pain relief.
Treatments aiding patient support in various health conditions.
Advanced therapies targeting central nervous system issues.
Products modulating immune responses for therapeutic benefits.
Funding Insights of Leiutis
Detailed funding history for Leiutis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Leiutis
Investment portfolio details for Leiutis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Leiutis
Detailed financials for Leiutis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Leiutis Comparisons
Peer comparison for Leiutis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Leiutis
Leiutis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Leiutis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Leiutis
Complete news archive for Leiutis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leiutis
Leiutis was founded in 2012.
Leiutis is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Oct 31, 2024, the latest employee count at Leiutis is 66.
Annual revenue of Leiutis is $10.25M as on Mar 31, 2024.
Leiutis is a pharmaceutical product innovation company specializing in nanotherapeutics to foster patient wellbeing through research and global partnerships. They focus on commercializing products in areas like pain management, supportive care, CNS disorders, and immunomodulators. Operating from Hyderabad, India, they engage in alliance partnerships for successful commercialization, emphasizing innovative treatments without promotional claims.
Leiutis's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Leiutis offers Nanotherapeutics for Pain Management, Nanotherapeutics for Supportive Care, Nanotherapeutics for CNS Disorders, and Nanotherapeutics for Immunomodulators.